Chief of Neurosurgery at MGH
Bob S. Carter, MD, PhD, is a board-certified neurosurgeon specializing in complex intracranial surgery including brain, pituitary, and skull base tumors, and brain aneurysms.
Dr. Carter is the Chair of the Department of Neurosurgery at Mass General and Visiting Professor at Harvard Medical School. One of the nation’s leading clinical neurosurgeons, Dr. Carter co-leads Massachusetts General Hospital’s brain tumor program, which brings together over 100 faculty and staff focused on brain tumor clinical care, research and education.
As a prolific researcher, Dr. Carter's scientific work has included the development of the first reported EGFRvIII directed CAR T-cell therapy, and the first characterizations of exosomes in glioblastoma. He is a principal investigator participating in the NIH-funded Extracellular RNA Communication Consortium. Dr. Carter leads a team of clinician scientists who have developed the role of “big data” in characterizing outcomes in oncologic and vascular neurosurgery.
Dr. Carter is extensively published, and he lectures internationally on neurosurgery topics. He is an editorial board member for the Journal of Neurosurgery and editorial advisory board member for Neurosurgery.
Visit website: https://www.massgeneral.org/doctors/20120/bob-carter
See also: Massachusetts General Hospital (MGH) - Largest teaching hospital of Harvard Medical School located in Boston
Bob Carter News
Parkinson's patient can swim again after stem cell transplant
Newsweek - 14-May-2020
Study and procedure represent a milestone in personalized medicine for Parkinson'sRead more...
Successful replacement of neurons lost in Parkinson's disease
Medical Xpress - 13-May-2020
New therapeutic personalized strategy could bring back movement to those sufferingRead more...